MS decreases the larger amplitude distribution in adult rats. by Jesús David Ayala-Rodríguez (17364296)

Subjects: “…glutamatergic events decreased…”

A noxious temperature decrease without a prior increase produces a subtly larger decrease in pain intensity. by Benedict J. Alter (9745466)

Change in health utilization measures by group and difference in magnitude of change between groups. by Emily Lyles (3174990)

Changes in FMD (% ± SD) in patient subgroup with decreased body weight during observation period. by Haruka Tamura (153793)

Subjects:

Preparatory neuronal activity in ALM is decreased, but remains significant in quiet trials devoid of movements. by Vahid Esmaeili (12700352)

Points represent regions where the cluster coefficient was significantly larger in HC compared to MCI, at sparsity level of 0.15. by Therese M. Gilligan (7460906)

The carotid canal area is larger on the unaffected side than on the affected side in patients with unilateral moyamoya disease, but the difference decreases according to the contra... by Yuki Oichi (11840776)

Increasing gaps and decreasing returns attenuate spending effects. by William Minozzi (8564712)

Summary of significant treatment × time effect. by Wensheng Xiao (16557866)

Receiver operating characteristic of sensitivity and specificity of Lnc THRIL and MiR-125b in CD patients vs. controls. by Azza Elamir (13924199)

Subjects:

Receiver operating characteristic of sensitivity and specificity of Lnc THRIL and MiR-125b in UC patients vs. controls. by Azza Elamir (13924199)

Subjects:

Receiver operating characteristic of sensitivity and specificity of Lnc THRIL and MiR-125b in UC vs. CD patients. by Azza Elamir (13924199)

Subjects:

Summary of significant single-arm time effect. by Wensheng Xiao (16557866)

Study Data. by Jonathan S. Jahr (2709088)

“…The study database was queried from a prospective study on sugammadex-related bradycardia, which was approved by the Human Studies Review Board and exempt from patient consent requirements. Patients were grouped into those that had or had not received dexamethasone as prophylaxis for PONV prior to the administration of sugammadex, and heart rate changes were evaluated 5 minutes after sugammadex administration. …”

Study outcomes. by Jonathan S. Jahr (2709088)

“…The study database was queried from a prospective study on sugammadex-related bradycardia, which was approved by the Human Studies Review Board and exempt from patient consent requirements. Patients were grouped into those that had or had not received dexamethasone as prophylaxis for PONV prior to the administration of sugammadex, and heart rate changes were evaluated 5 minutes after sugammadex administration. …”

Patient characteristics. by Jonathan S. Jahr (2709088)

“…The study database was queried from a prospective study on sugammadex-related bradycardia, which was approved by the Human Studies Review Board and exempt from patient consent requirements. Patients were grouped into those that had or had not received dexamethasone as prophylaxis for PONV prior to the administration of sugammadex, and heart rate changes were evaluated 5 minutes after sugammadex administration. …”

Correlation between treatment-induced changes in lumbar motor control and N150 amplitude. by Soheila Qanbari (20455173)

Subjects:

Linear relationships (Spearman’s r (p-value)) the treatment-induced changes in clinical and neurophysiological data. by Soheila Qanbari (20455173)

Subjects:

Training-induced changes in bipedal stance. by Cristina Dolciotti (16317330)

Subjects:

Changes in MMSE scores by age group. by Juneyoung Heo (20161057)